Compliance with osteoporosis drug therapy and risk of fracture

被引：0
|
作者：
D. Weycker
D. Macarios
J. Edelsberg
G. Oster
机构：
[1] Four Davis Court,Policy Analysis Inc. (PAI)
[2] Amgen,undefined
[3] Inc.,undefined
来源：
Osteoporosis International | 2007年 / 18卷
关键词：
Adherence; Compliance; Fractures; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 277
页数：6
相关论文
共 50 条
  • [21] Alendronate 70 therapy in elderly women with post-menopausal osteoporosis: the problem of compliance
    Sewerynek, Ewa
    Malkowski, Bogdan
    Karzewnik, Ewa
    Stepien-Klos, Wioletta
    Tabaszewska, Maria
    Lasota, Marek
    Krupinska, Grazyna
    Gladalska, Anna
    Horst-Sikorska, Wanda
    Stuss, Michal
    ENDOKRYNOLOGIA POLSKA, 2011, 62 (01) : 24 - 29
  • [22] Compliance with drug therapies for the treatment and prevention of osteoporosis
    McCombs, JS
    Thiebaud, P
    McLaughlin-Miley, C
    Shi, JH
    MATURITAS, 2004, 48 (03) : 271 - 287
  • [23] Risk for osteoporosis and fracture with glucocorticoids
    Urquiaga, Mariana
    Saag, Kenneth G.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2022, 36 (03):
  • [24] Fracture healing and drug therapies in osteoporosis
    Hoang-Kim, Amy
    Gelsomini, Letizia
    Luciani, Deianira
    Moroni, Antonio
    Giannini, Sandro
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2009, 6 (02) : 136 - 143
  • [25] Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis
    Liu, J.
    Guo, H.
    Rai, P.
    Pinto, L.
    Barron, R.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (11) : 2409 - 2417
  • [26] Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan
    Soong, Y. -K.
    Tsai, K. -S.
    Huang, H. -Y.
    Yang, R. -S.
    Chen, J. -F.
    Wu, P. C. -H.
    Huang, K. -E.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (02) : 511 - 521
  • [27] Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk
    Curtis, Jeffrey R.
    Saag, Kenneth G.
    Arora, Tarun
    Wright, Nicole C.
    Yun, Huifeng
    Daigle, Shanette
    Matthews, Robert
    Delzell, Elizabeth
    MEDICAL CARE, 2020, 58 (05) : 419 - 426
  • [28] The effect of zoledronic acid on the fracture risk in men with osteoporosis
    R. Spiegel
    P. P. Nawroth
    C. Kasperk
    Journal of Endocrinological Investigation, 2014, 37 : 229 - 232
  • [29] How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study
    Gonnelli, Stefano
    Caffarelli, Carla
    Rossi, Stefania
    Di Munno, Ombretta
    Malavolta, Nazzarena
    Isaia, Giancarlo
    Muratore, Maurizio
    D'Avola, Giovanni
    Gatto, Salvatore
    Minisola, Giovanni
    Nuti, Ranuccio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (03) : 459 - 468
  • [30] How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study
    Stefano Gonnelli
    Carla Caffarelli
    Stefania Rossi
    Ombretta Di Munno
    Nazzarena Malavolta
    Giancarlo Isaia
    Maurizio Muratore
    Giovanni D’Avola
    Salvatore Gatto
    Giovanni Minisola
    Ranuccio Nuti
    Aging Clinical and Experimental Research, 2016, 28 : 459 - 468
12345